Company: CERO
Filing Date: 2025-11-19
Form Type: 10-Q
Source: 0001213900-25-112619
Chunk: 445

Company: CERO THERAPEUTICS HOLDINGS, INC.
Filing Date: 2025-11-19
Form: 10-Q
Item: Item 4
Chunk 445
---
 Exchange
Act, the registrant caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

    CERO THERAPEUTICS
    HOLDINGS, INC.

    Date: November 19, 2025
    By:
    /s/
    Chris Ehrlich

    Name: 
    Chris Ehrlich

    Title:
    Chairman and Chief Executive
    Officer

    (Principal Executive Officer)

    Date: November 19, 2025
    By:
    /s/
    Andrew Kucharchuk

    Name:
    Andrew Kucharchuk

    Title:
    Chief Financial Officer

    (Principal Financial and
    Accounting Officer)

54

NONE
NONE

http://fasb.org/srt/2025#ChiefExecutiveOfficerMember

0001870404
false
Q3
--12-31

    0001870404

    2025-01-01
    2025-09-30

    0001870404
    
      cero:CommonStockParValue00001PerShareMember

    2025-01-01
    2025-09-30

    0001870404
    
      cero:WarrantsEachWarrantExercisableForOneTwoThousandthsOfAShareOfCommonStockMember

    2025-01-01
    2025-09-30

    0001870404

    2025-11-19

    0001870404

    2025-09-30

    0001870404

    2024-12-31

    0001870404
    
      cero:SeriesCConvertiblePreferredStockMember

    2025-09-30

    0001870404
    
      cero:SeriesCConvertiblePreferredStockMember

    2024-12-31

    0001870404
    
      cero:SeriesDConvertiblePreferredStockMember

    2025-09-30

    0001870404
    
      cero:SeriesDConvertiblePreferredStockMember

    2024-12-31

    0001870404
    
      cero:SeriesAConvertiblePreferredStockMember

    2025-09-30

    0001870404
    
      cero:SeriesAConvertiblePreferredStockMember

    2024-12-31

    000